Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients. 2002

C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
Department of Neuroimmunology, Max-Planck-Institute for Neurobiology, D-82152 Martinsried, Germany.

We analysed the humoral immune response to glatiramer acetate (GA, Copaxone) in 20 multiple sclerosis patients treated with GA, 20 patients not treated with GA and 20 normal control subjects. Using an ELISA for detection of total GA-reactive immunoglobulins (all isotypes), all treated patients but also 3/20 untreated and 8/20 healthy subjects scored positive at 1:20 plasma dilutions. At higher dilutions, 5/20 treated patients and two healthy donors had relatively high levels of anti-GA antibodies. Isotype and IgG subclass analysis revealed that the two antibody-positive normal subjects had IgM and small titers of IgG1 or IgG2 antibodies. In contrast, 18 of 20 GA-treated patients, had low but significant titers of GA-reactive IgG4 antibodies. This finding is consistent with the previously described GA-mediated induction of T-helper 2 (TH2)-like regulatory T cells.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068717 Glatiramer Acetate A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS. Copaxone,Glatiramer,TV 5010,TV-5010,TV5010,5010, TV,Acetate, Glatiramer
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
August 2006, Journal of neuroimmunology,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
March 2001, Journal of neurology, neurosurgery, and psychiatry,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
July 2005, Expert review of neurotherapeutics,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
February 2004, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
April 2000, The Journal of clinical investigation,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
March 2002, The Journal of clinical investigation,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
February 2005, Neurologic clinics,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
July 2001, Expert opinion on pharmacotherapy,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
April 2007, Neuropsychiatric disease and treatment,
C Farina, and V Vargas, and N Heydari, and T Kümpfel, and E Meinl, and R Hohlfeld
June 2003, Neuropediatrics,
Copied contents to your clipboard!